| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| F0, | F1 coupling factor |
| tc | transcutaneous; translational control |
| tcRNA | translational control ribonucleic acid |
| TI | inversion time; temporal integration; terminal ileum; thalassemia intermedia; therapeutic index; tho... |
| E-C coupling | Excitation-contraction coupling |
|---|---|
| CF1 | Coupling Factor 1 |
| ECC | Excitation-contraction coupling |
| CI | coupling interval |
| post-translational modification | The enzymatic processing of a polypeptide chain after translation from messenger RNA and after peptide bond formation has occurred. Examples include glycosylation, acylation, limited proteolysis, phosphorylation, isoprenylation. (10 Oct 1997) |
|---|---|
| protein processing, post-translational | Any of various enzymically catalyzed post-translational modifications of peptides or proteins in the cell of origin. These modifications include carboxylation, hydroxylation, acetylation, phosphorylation, methylation, glycosylation, oxidation-reduction, degradation and lysis, peptide bond formation, and changes in molecular weight and electrophoretic motility. (12 Dec 1998) |
| translational control | <molecular biology> The control of protein synthesis by regulation of the translation step, for example by selective usage of preformed mRNA or instability of the mRNA. (18 Nov 1997) |
| translational repressor | A molecule that blocks translation by binding to a messenger RNA. (09 Oct 1997) |
| viscous mechanical coupling | <cell biology> Method by which adjacent cilia are synchronised in a field. Coupling is through the transmission of mechanical forces, rather than of a synchronising signal. (18 Nov 1997) |
| chemiosmotic coupling | The linking of ATP synthesis to electrontransfer by way of an electrochemical hydrogen cation gradient across amembrane. (09 Oct 1997) |
| metabolic coupling | <cell biology, molecular biology> Transfer between tissue cells in contact of low molecular weight metabolites such as nucleotides and amino acids. Transfer is via channels constituted by the connexons of gap junctions and does not involve exchange with the extracellular medium. First observed in cultures of animal cells in which radio labelled purines were transferred from wild type cells to mutants unable to utilise exogenous purines. (27 Jun 1999) |
| constant coupling | Where several premature beats are seen, the interval between each of them and the preceding normal beat is constant. Synonym: constant coupling. Variable coupling, where several extrasystoles are seen, the interval between each of them and the preceding sinus beat varies. (05 Mar 2000) |
| coupling | <biochemistry> The linking of two independent processes by a common intermediate, for example the coupling of electron transport to oxidative phosphorylation or the ATP ADP conversion to transport processes. (18 Nov 1997) |
| coupling defect | See: familial goiter. (05 Mar 2000) |
| coupling factor | Protein responsible for coupling transmembrane potentials to ATP synthesis in chloroplasts and mitochondria. Include ATP synthesising enzymes (F1 in mitochondrion), that can also act as ATP ases. (18 Nov 1997) |
| coupling factors | Proteins that restore phosphorylating ability to mitochondria that have lost it, i.e., have become "uncoupled" so that oxidation and electron transport no longer produces ATP. Usually termed coupling factor F1, F2, etc. Synonym: C factors. (05 Mar 2000) |
| coupling interval | The interval, usually expressed in hundredths of a second, between a normal sinus beat and the ensuing premature beat. (05 Mar 2000) |
| coupling phase | The physical relationship of two syntenic genes. If they are on the same chromosome, they are said to be "in coupling" or "in the cis phase"; if on opposite members of a chromosome pair, "in repulsion" or "in the trans phase." (05 Mar 2000) |
| signal response coupling | The cascade of processes by which an extracellular signal (typically a hormone or neurotransmitter) interacts with a receptor at the cell surface, causing a change in the level of a second messenger for example calcium or cyclic AMP) and ultimately effects a change in the cells functioning (for example: triggering glucose uptake or initiating cell division). Can also be applied to sensory signal transduction, for example of light at photoreceptors. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|